Oxyrane UK

About:

Oxyrane UK is a biopharmaceutical company developing biosuperior enzyme replacement therapies to treat inherited diseases.

Website: http://www.oxyrane.com

Top Investors: Forbion Capital Partners, Morningside Group, New Science Ventures

Description:

Oxyrane UK Limited is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases. Founded in 2006, the Company is headquartered in Manchester, United Kingdom with research facilities in Ghent, Belgium.